SpectraCure AB (publ) (OM: SPEC)
Health Care · Health Care Equipment & Supplies · SE
Skr0.04
+8.64% today · -75.5% 1Y
SpectraCure AB (publ) (OM: SPEC) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $2.35M and employs 13 people.
Over the last twelve months the share price has lost 75.5%, trading between 0.03 and 0.32.
Tweenvest scores SpectraCure AB (publ) across four factors: quality 44/100, value 49/100. Its strongest factor is value.
SPEC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.35M
- Revenue (TTM)
- $-24.97K
- P/E
- —
- EPS
- -0.07
- Dividend yield
- —
- Beta (5Y)
- 0.44
- 52-week high
- Skr0.32
- 52-week low
- Skr0.03
- Avg volume (3M)
- —
- Shares outstanding
- 570.60M
- Employees
- 13
- Next earnings
- —
About SpectraCure AB (publ)
SpectraCure AB (publ) specializes in oncology, developing innovative cancer treatments that harness laser light and photodynamic agents. A cornerstone of their research is the IDOSE software, which powers an interstitial photodynamic therapy (PDT) system. This cutting-edge system is currently in Phase II clinical trials, where its efficacy in addressing solid tumors is being evaluated. The Swedish company, established in Lund in 2003, continues to advance its therapeutic solutions.
- Founded
- 2003
- Listed since
- Jul 1, 2015
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.64 | +2.19% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $378.81 | +1.19% |
| Stryker CorporationNYSE: SYK | $126.37B | $329.45 | +0.53% |
| Medtronic plcNYSE: MDT | $119.49B | $93.35 | +1.14% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €163.20 | +1.24% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $50.37 | +2.03% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $192.00 | +2.33% |
Figures last refreshed Aug 18, 2026.